The shift to a product-led culture wasn't a formal launch. The CEO began by stating "we are product-led" aspirationally, then relentlessly reinforced this message in every meeting and report. This constant repetition, backed by operational changes, gradually and organically transformed the company's identity and behavior.

Jade's CEO Tom Frohlich draws inspiration from legendary drug hunter Dr. Paul Janssen. Janssen would motivate his teams by reminding them, "hurry up because the patients are out there and they're waiting." This frames the work not as a scientific or business exercise, but as a moral imperative, fostering a powerful sense of purpose and urgency.

To accelerate innovation, e.l.f. Beauty's CEO holds product review meetings open to any employee. This radical transparency ensures the company moves at 'e.l.f. speed' and leverages insights from team members who represent their core community. It prioritizes collective intelligence and agility over traditional corporate secrecy.

Sana CEO Steve Harr actively questions whether the company's groundbreaking science can translate into a scalable, commercially viable therapy. This internal pressure focuses the team on solving not just the scientific challenges ("does it work?"), but also manufacturing ("can you scale it?") and the commercial model required for a true cure.

To humanize R&D and maintain motivation, biotech leaders bring patients into the company. This practice directly connects scientists with the human impact of their work, grounding the entire team in their shared purpose, especially on difficult days.

The debate between being product-led vs. sales-led is a false dichotomy that creates friction. Instead, frame all functions as fundamentally 'customer-driven.' This reframing encourages product teams to view sales requests not as distractions, but as valuable, direct insights into customer needs.

Successful biotech teams are built on four pillars: genuine scientific curiosity, professional integrity to face data honestly (avoiding your own "Kool-Aid"), the ability to connect science to viable business outcomes, and a low-friction human environment free from politics and drama, which is the ultimate driver.

In companies with long development timelines, it's crucial to maintain team motivation. The CEO advises ensuring the business team celebrates lab breakthroughs and the lab team celebrates business milestones. This creates a shared sense of progress and counters the inevitable setbacks of R&D.

Developing a new medicine is 'the toughest team sport,' requiring hundreds of people across diverse disciplines over many years. In this context, culture isn't a perk; it's the fundamental 'glue' that enables these disparate teams to work in concert and succeed. Without it, even the best individual players will fail.